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W h at is tu b e rc u lo s is  (TB)?
Tuberculosis (TB) is a disease caused by bacteria 
that are spread from person to person through 
the air. TB usually affects the lungs, but it can also 
affect other parts of the body, such as the brain, the 
kidneys, or the spine. In most cases, TB is treatable 
and curable; however, persons with TB can die if 
they do not get proper treatment.
W h at is m u lt i -d ru g  re s is ta n t  
tu b e rc u lo s is  (MDR TB)?
Multidrug-resistant TB (MDR TB) is TB that is 
resistant to at least two of the best anti-TB drugs, 
isoniazid and rifampin. These drugs are considered 
first-line drugs and are used to treat all persons with 
TB disease.
W h at is e x te n s iv e ly  d ru g - re s is ta n t  
tu b e rc u lo s is  (XDR TB)?
Extensively drug resistant TB (XDR TB) is a rare type 
of MDR TB. XDR TB is defined as TB which is resistant 
to isoniazid and rifampin, plus resistant to any 
fluoroquinolone and at least one of three injectable 
second-line drugs (i.e., amikacin, kanamycin, or 
capreomycin).
Because XDR TB is resistant to the most powerful 
first-line and second-line drugs, patients are left 
with treatment options that are much less effective.
XDR TB is of special concern for persons with HIV 
infection or other conditions that can weaken the 
immune system. These persons are more likely to 
develop TB disease once they are infected, and also 
have a higher risk of death once they develop TB.
How is TB s p re a d ?
Drug-susceptible TB and drug-resistant TB are 
spread the same way. TB bacteria are put into the 
air when a person with TB disease of the lungs or 
throat coughs, sneezes, speaks, or sings. These 
bacteria can float in the air for several hours, 
depending on the environment. Persons who 
breathe in the air containing these TB bacteria can 
become infected.
TB is not spread by
• shaking someone's hand
• sharing food or drink
• touching bed linens or toilet seats
• sharing toothbrushes
• kissing
How d o e s  d ru g  re s is ta n c e  h a p p e n ?
Resistance to anti-TB drugs can occur when these 
drugs are misused or mismanaged. Examples include 
when patients do not complete their full course of 
treatment; when health-care providers prescribe the 
wrong treatment, the wrong dose, or length of time 
for taking the drugs; when the supply of drugs is 
not always available; or when the drugs are of poor 
quality.
Are in te rn a t io n a l  t ra v e le rs  a t  risk  
o f  g e t t in g  d ru g - re s is ta n t  TB w hile  
trav e l in g ?
Although MDR and XDR TB are occurring globally, 
they are still rare. HIV-infected travelers are at greatest 
risk if they come in contact with a person with MDR 
or XDR TB. All travelers should avoid high risk settings 
where there are no infection control measures in 
place.
Documented places where transmission has occurred 
include crowded hospitals, prisons, homeless shelters, 
and other settings where susceptible persons come in 
contact with persons with TB disease.
Air travel itself carries a relatively low risk of infection 
with TB of any kind.
W h at is t h e  risk  o f  ac q u ir in g  TB on  
a n  a irp lan e?
The risk of acquiring any type of TB depends on 
several factors, such as extent of disease in the patient 
with TB, duration of exposure, and ventilation. Most 
important, there must be someone with infectious 
TB disease on the same flight to present any risk. If 
someone on the flight does have TB disease, persons 
on flights lasting 8 hours or longer are at greater risk 
than persons on shorter flights.
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How can  TB b e  p re v e n te d ?
Travelers should avoid close contact or prolonged 
time with known TB patients in crowded, enclosed 
environments (for example, clinics, hospitals, 
prisons, or homeless shelters).
Travelers who will be working in clinics, hospitals, 
or other health care settings where TB patients are 
likely to be encountered should consult infection 
control or occupational health experts. They should 
ask about administrative and environmental 
procedures for preventing exposure to TB. Once 
those procedures are implemented, additional 
measures could include using personal respiratory 
protective devices.
Is t h e r e  a  v acc in e  to  p re v e n t  TB?
Yes, there is a vaccine for TB disease called Bacille 
Calmette-Guerin (BCG) (http://www.cdc.gov/tb/ 
publications/factsheets/prevention/BCG.htm). It 
is used in some countries to prevent severe forms 
of TB in children. However, BCG is not generally 
recommended in the United States because it has 
limited effectiveness for preventing TB overall.
W h at sh o u ld  I d o  b e fo re  t rav e l in g  
in te rn a tio n a l ly ?
Travelers who anticipate possible prolonged 
exposure to persons with TB (for example, those 
who expect to come in contact routinely with clinic, 
hospital, prison, or homeless shelter populations) 
should have a tuberculin skin test (TST) or TB 
blood test before leaving the United States. If the 
reaction to the TST or TB blood test is negative, 
they should have a repeat test 8 to 10 weeks 
after returning to the United States. Additionally, 
annual testing may be recommended for those 
who anticipate repeated or prolonged exposure or 
an extended stay over a period of years. Because 
persons with HIV infection are more likely to have 
an impaired response to both the TST and TB blood 
test, travelers who are HIV positive should tell their 
physicians about their HIV infection status.
W h at sh o u ld  I d o  if I th in k  I h av e  
b e e n  e x p o s e d  to  s o m e o n e  w ith  TB 
d ise a se ?
If you think you have been exposed to someone 
with TB disease, you should contact your doctor or 
local health department about getting a TB skin test 
or TB blood test. And tell the doctor or nurse when 
you spent time with this person.
W h at a re  t h e  s y m p to m s  o f  TB d ise a se ?
The general symptoms of TB disease include feelings 
of sickness or weakness, weight loss, fever, and night 
sweats. The symptoms of TB disease of the lungs also 
include coughing, chest pain, and the coughing up of 
blood. Symptoms of TB disease in other parts of the 
body depend on the area affected. If you have these 
symptoms, you should contact your doctor or local 
health department.
W h ere  can  I f ind  o th e r  h e a l th  
in fo rm a tio n  a b o u t  m y  trav e l  
d e s t in a t io n ?
CDC's Travelers' Health website (http://wwwn.cdc.gov/ 
travel/destinationList.aspx) lists health information for 
travelers by destination.
CDC issues travel notices (http://wwwnc.cdc.gov/ 
travel/notices.htm) when there is a health threat to 
travelers. These notices describe levels of risk for the 
traveler and recommended preventive measures to 
take at each level of risk. Travel notices are organized 
by disease and by travel destination.
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